Shira Greenfeld

843 total citations · 1 hit paper
36 papers, 493 citations indexed

About

Shira Greenfeld is a scholar working on Genetics, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Shira Greenfeld has authored 36 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 23 papers in Epidemiology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Shira Greenfeld's work include Inflammatory Bowel Disease (28 papers), Microscopic Colitis (21 papers) and Pregnancy and Medication Impact (5 papers). Shira Greenfeld is often cited by papers focused on Inflammatory Bowel Disease (28 papers), Microscopic Colitis (21 papers) and Pregnancy and Medication Impact (5 papers). Shira Greenfeld collaborates with scholars based in Israel, United States and Sweden. Shira Greenfeld's co-authors include Pinchas Akiva, Maytal Bivas‐Benita, Natalie Flaks‐Manov, Shirley Shapiro Ben David, Uri Lerner, Yoav Yehezkelli, Nir Kalkstein, Tamar Sudry, Barak Mizrahi and Iris Dotan and has published in prestigious journals such as Gastroenterology, Gut and BMJ.

In The Last Decade

Shira Greenfeld

34 papers receiving 486 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study

2023 207 citations Natalie Flaks‐Manov, Yoav Yehezkelli et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shira Greenfeld Israel	10	180	171	156	141	94	36	493
Ushma Galal United Kingdom	13	130 0.7×	44 0.3×	61 0.4×	111 0.8×	53 0.6×	30	560
Emily M. Whettlock United Kingdom	5	159 0.9×	23 0.1×	96 0.6×	41 0.3×	40 0.4×	7	362
Lokesh Shahani United States	14	60 0.3×	38 0.2×	165 1.1×	172 1.2×	42 0.4×	54	527
Vincenza Di Stasi Italy	11	37 0.2×	42 0.2×	130 0.8×	45 0.3×	61 0.6×	27	606
Tahnee Bridson Australia	9	54 0.3×	55 0.3×	213 1.4×	150 1.1×	22 0.2×	14	417
Jean‐Christophe Goffard Belgium	12	212 1.2×	21 0.1×	753 4.8×	223 1.6×	62 0.7×	43	1.0k
Claire Andréjak France	14	192 1.1×	25 0.1×	555 3.6×	595 4.2×	67 0.7×	49	1.1k
Maya Gopalakrishnan India	9	49 0.3×	118 0.7×	64 0.4×	18 0.1×	43 0.5×	43	326
Bjarni á Steig Faroe Islands	9	290 1.6×	18 0.1×	200 1.3×	35 0.2×	147 1.6×	23	470
Kimberly Stone United States	9	290 1.6×	13 0.1×	711 4.6×	54 0.4×	122 1.3×	14	1.0k

Countries citing papers authored by Shira Greenfeld

Since Specialization

Citations

This map shows the geographic impact of Shira Greenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shira Greenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shira Greenfeld more than expected).

Fields of papers citing papers by Shira Greenfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shira Greenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shira Greenfeld. The network helps show where Shira Greenfeld may publish in the future.

Co-authorship network of co-authors of Shira Greenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Shira Greenfeld. A scholar is included among the top collaborators of Shira Greenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shira Greenfeld. Shira Greenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

David, Shirley Shapiro Ben, et al.. (2025). AI driven decision support reduces antibiotic mismatches and inappropriate use in outpatient urinary tract infections. npj Digital Medicine. 8(1). 61–61. 5 indexed citations

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2024). Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN. Inflammatory Bowel Diseases. 31(3). 655–664. 3 indexed citations

Focht, Gili, Shira Greenfeld, Amir Ben‐Tov, et al.. (2024). Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort. Gastroenterology. 166(5). 815–825.e22. 5 indexed citations

Focht, Gili, Shira Greenfeld, Revital Kariv, et al.. (2024). Enteral nutrition compared with corticosteroids in children with Crohn's disease: A long‐term nationwide study from the epi‐IIRN. Alimentary Pharmacology & Therapeutics. 60(2). 224–232. 2 indexed citations

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2024). Predictors of Complicated Disease Course in Adults and Children With Crohn’s Disease: A Nationwide Study from the epi-IIRN. Inflammatory Bowel Diseases. 30(12). 2370–2379. 3 indexed citations

Yerushalmy‐Feler, Anat, Yiska Loewenberg Weisband, Shira Greenfeld, et al.. (2024). Peripheral Blood Eosinophilia at Diagnosis of Inflammatory Bowel Disease Is Associated With Severe Disease Course: A Nationwide Study From the epi-IIRN Cohort. Journal of Crohn s and Colitis. 19(2). 1 indexed citations

Atia, Ohad, Gili Focht, Shira Greenfeld, et al.. (2024). Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN. Inflammatory Bowel Diseases. 31(3). 617–624. 3 indexed citations

Ledder, Oren, Esther Orlanski‐Meyer, Yiska Loewenberg Weisband, et al.. (2023). Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN. Inflammatory Bowel Diseases. 30(1). 1–8. 3 indexed citations

Bilu, Yonatan, Natalie Flaks‐Manov, Maytal Bivas‐Benita, et al.. (2023). Data-Driven Assessment of Adolescents’ Mental Health During the COVID-19 Pandemic. Journal of the American Academy of Child & Adolescent Psychiatry. 62(8). 920–937. 28 indexed citations

10.

Atia, Ohad, Idan Goren, Shira Greenfeld, et al.. (2023). 5‐aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease—A nationwide cohort study. Alimentary Pharmacology & Therapeutics. 57(9). 1004–1013. 12 indexed citations

11.

Atia, Ohad, Gili Focht, Shira Greenfeld, et al.. (2023). Durability of the First Biologic in Patients with Crohn’s Disease: A Nationwide Study from the epi-IIRN. Journal of Crohn s and Colitis. 18(1). 38–46. 6 indexed citations

12.

Focht, Gili, Ohad Atia, Shira Greenfeld, et al.. (2023). OP12 Does early initiation of biologics change the natural history of IBD? a nationwide study from the epi-IIRN. Journal of Crohn s and Colitis. 17(Supplement_1). i17–i18. 2 indexed citations

13.

David, Shirley Shapiro Ben, et al.. (2023). A Nationwide Digital Multidisciplinary Intervention Aimed at Promoting Pneumococcal Vaccination in Immunocompromised Patients. Vaccines. 11(8). 1355–1355. 5 indexed citations

14.

Bilu, Yonatan, Natalie Flaks‐Manov, Inbal Goldshtein, et al.. (2023). Youth Mental Health Outcomes up to Two Years After SARS-CoV-2 Infection Long-COVID or Long-Pandemic Syndrome: A Retrospective Cohort Study. Journal of Adolescent Health. 73(4). 701–706. 3 indexed citations

15.

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2023). Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN. Inflammatory Bowel Diseases. 30(2). 213–221. 6 indexed citations

16.

Atia, Ohad, Eric I. Benchimol, Shira Greenfeld, et al.. (2022). Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study. Clinical Gastroenterology and Hepatology. 21(10). 2639–2648.e6. 12 indexed citations

17.

Hochner, Hagit, Baruch Yerushalmi, Ronit Calderon‐Margalit, et al.. (2022). Pre- and Perinatal Factors Predicting Inflammatory Bowel Disease: A Population-Based Study with Fifty Years of Follow-Up. Journal of Crohn s and Colitis. 16(9). 1397–1404. 7 indexed citations

18.

Gorelik, Yuri, Sigal Pressman, Gili Focht, et al.. (2021). Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN. Gut. 71(2). 287–295. 17 indexed citations

19.

Atia, Ohad, Esther Orlanski‐Meyer, Shira Greenfeld, et al.. (2021). Improved Outcomes of Paediatric and Adult Crohn’s Disease and Association With Emerging Use of Biologics–A Nationwide Study From the Epi-IIRN. Journal of Crohn s and Colitis. 16(5). 778–785. 19 indexed citations

20.

Atia, Ohad, Esther Orlanski‐Meyer, Shira Greenfeld, et al.. (2021). Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN. Journal of Crohn s and Colitis. 16(5). 796–803. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact